484 related articles for article (PubMed ID: 19254517)
21. Selective serotonin reuptake inhibitor use during early pregnancy and congenital malformations: a systematic review and meta-analysis of cohort studies of more than 9 million births.
Gao SY; Wu QJ; Sun C; Zhang TN; Shen ZQ; Liu CX; Gong TT; Xu X; Ji C; Huang DH; Chang Q; Zhao YH
BMC Med; 2018 Nov; 16(1):205. PubMed ID: 30415641
[TBL] [Abstract][Full Text] [Related]
22. Pregnancy outcome following maternal use of the new selective serotonin reuptake inhibitors: a prospective controlled multicenter study.
Kulin NA; Pastuszak A; Sage SR; Schick-Boschetto B; Spivey G; Feldkamp M; Ormond K; Matsui D; Stein-Schechman AK; Cook L; Brochu J; Rieder M; Koren G
JAMA; 1998 Feb; 279(8):609-10. PubMed ID: 9486756
[TBL] [Abstract][Full Text] [Related]
23. Counseling pregnant women treated with paroxetine. Concern about cardiac malformations.
Einarson A; Koren G
Can Fam Physician; 2006 May; 52(5):593-4. PubMed ID: 16739830
[TBL] [Abstract][Full Text] [Related]
24. Increase in use of selective serotonin reuptake inhibitors in pregnancy during the last decade, a population-based cohort study from the Netherlands.
Bakker MK; Kölling P; van den Berg PB; de Walle HE; de Jong van den Berg LT
Br J Clin Pharmacol; 2008 Apr; 65(4):600-6. PubMed ID: 17953715
[TBL] [Abstract][Full Text] [Related]
25. Should paroxetine be used to treat depression during pregnancy?
Mintzes B; Jureidini J
Am J Psychiatry; 2008 Nov; 165(11):1487; author reply 1487-8. PubMed ID: 18981077
[No Abstract] [Full Text] [Related]
26. Antidepressant use during pregnancy and the risk of major congenital malformations in a cohort of depressed pregnant women: an updated analysis of the Quebec Pregnancy Cohort.
Bérard A; Zhao JP; Sheehy O
BMJ Open; 2017 Jan; 7(1):e013372. PubMed ID: 28082367
[TBL] [Abstract][Full Text] [Related]
27. Pharmacologic factors associated with transient neonatal symptoms following prenatal psychotropic medication exposure.
Oberlander TF; Misri S; Fitzgerald CE; Kostaras X; Rurak D; Riggs W
J Clin Psychiatry; 2004 Feb; 65(2):230-7. PubMed ID: 15003078
[TBL] [Abstract][Full Text] [Related]
28. Antidepressants in pregnancy: a systematic review.
Udechuku A; Nguyen T; Hill R; Szego K
Aust N Z J Psychiatry; 2010 Nov; 44(11):978-96. PubMed ID: 21034181
[TBL] [Abstract][Full Text] [Related]
29. Paroxetine use in pregnancy and increased risk of heart defects: Evaluating the evidence.
Einarson A
Can Fam Physician; 2010 Aug; 56(8):767-8. PubMed ID: 20705881
[TBL] [Abstract][Full Text] [Related]
30. [Medical treatment of depression during pregnancy and breastfeeding].
Nielsen RE; Stage KB; Christensen PM; Mortensen S; Andersen LL; Damkier P
Ugeskr Laeger; 2007 Apr; 169(16):1442-4. PubMed ID: 17484841
[TBL] [Abstract][Full Text] [Related]
31. Antidepressants and children. Buried data can be hazardous to a company's health.
Marshall E
Science; 2004 Jun; 304(5677):1576-7. PubMed ID: 15192185
[No Abstract] [Full Text] [Related]
32. Selective serotonin reuptake inhibitors in pregnancy.
Bellissima V; Ververs TF; Visser GH; Gazzolo D
Curr Med Chem; 2012; 19(27):4554-61. PubMed ID: 22876893
[TBL] [Abstract][Full Text] [Related]
33. Pregnancy outcome following gestational exposure to venlafaxine: a multicenter prospective controlled study.
Einarson A; Fatoye B; Sarkar M; Lavigne SV; Brochu J; Chambers C; Mastroiacovo P; Addis A; Matsui D; Schuler L; Einarson TR; Koren G
Am J Psychiatry; 2001 Oct; 158(10):1728-30. PubMed ID: 11579012
[TBL] [Abstract][Full Text] [Related]
34. [Use of SSRIs during pregnancy and possible consequences for the development of the child].
van der Veere CN; Bos AF
Ned Tijdschr Geneeskd; 2007 Dec; 151(52):2873-4. PubMed ID: 18257430
[TBL] [Abstract][Full Text] [Related]
35. Withdrawal syndromes after paroxetine and sertraline discontinuation.
Fava GA; Grandi S
J Clin Psychopharmacol; 1995 Oct; 15(5):374-5. PubMed ID: 8830071
[No Abstract] [Full Text] [Related]
36. Paroxetine exposure during pregnancy and the risk of cardiac malformations: what is the evidence?
Bérard A
Birth Defects Res A Clin Mol Teratol; 2010 Mar; 88(3):171-4. PubMed ID: 19950383
[No Abstract] [Full Text] [Related]
37. Paroxetine. An update of its pharmacology and therapeutic use in depression and a review of its use in other disorders.
Gunasekara NS; Noble S; Benfield P
Drugs; 1998 Jan; 55(1):85-120. PubMed ID: 9463792
[TBL] [Abstract][Full Text] [Related]
38. Selective serotonin reuptake inhibitor use during pregnancy and possible neonatal complications.
Cantor Sackett J; Weller RA; Weller EB
Curr Psychiatry Rep; 2009 Jun; 11(3):253-7. PubMed ID: 19470288
[TBL] [Abstract][Full Text] [Related]
39. Maternal use of selective serotonin re-uptake inhibitors in early pregnancy and infant congenital malformations.
Källén BA; Otterblad Olausson P
Birth Defects Res A Clin Mol Teratol; 2007 Apr; 79(4):301-8. PubMed ID: 17216624
[TBL] [Abstract][Full Text] [Related]
40. Newer generation antidepressants for depressive disorders in children and adolescents.
Hetrick SE; McKenzie JE; Cox GR; Simmons MB; Merry SN
Cochrane Database Syst Rev; 2012 Nov; 11(11):CD004851. PubMed ID: 23152227
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]